Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Lauq Nazali: 10 grams of Lauq nazli thrice a day with Luke warm water for 28 days.
Control Intervention1: NIL: NIL
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1.Symptoms persisted for more than 4 days per week or more than 4 weeks per year and at least one of the following rhinitis-associated conditions: nasal congestion, rhinorrhea, sneezing and nasal itching 2.Patients who will give consent and able to do follow up
Exclusion criteria
Exclusion criteria: 1.Patients suffering from systemic illness like Hypertension, DM, Malignancy, Liver or Kidney dysfunction 2.Patients suffering from congenital nasal abnormalities like nasal dermoid cysts, congenital midline nasal masses, Deviated Nasal Septum, Atrophic rhinitis, Sinusitis, Hypertrophic turbinates, Adenoidal hypertrophy, Foreign bodies or Asthma 3.Patients below 18 and above 50 years 4.Patients with past history of nose surgery 5.Patients had received systematically administered corticosteroids, antihistamines, decongestants or CAM therapy within 02 weeks prior to enrolment 6.Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Changes in Total Nasal Symptom Score (TNSS) and 2.Allergic Rhinitis Control Test (ARCT) Timepoint: 0th Day, 07th Day, 14th Day, 21st Day, 28th Day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Improvement in Mini Rhinoconjunctivitis Quality of Life Questionnaire (Mini RQLQ) 2. AEC Timepoint: 0th Day, 07th Day, 14th Day, 21st Day, 28th Day | — |
Countries
India
Contacts
Public ContactDr Aafreen Siddiqui
National Institute of Unani Medicine
Outcome results
None listed